Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scantek Medical was a medical technology company focused on the early detection of breast cancer through non-invasive diagnostic tools. The company's primary product, the BreastCare Digital Thermal System (DTS), utilized infrared thermography to identify abnormal heat patterns associated with tumor growth. Positioned as an adjunct to traditional mammography, the device was intended to improve detection rates, especially in younger women or those with dense breast tissue. The technology aimed to provide a radiation-free and painless alternative for monitoring breast health. Although the BreastCare system received FDA 510(k) clearance in 1998, the company struggled with commercial adoption and reimbursement, eventually ceasing active operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scantek Medical.